Beyond a two-tier model: equitable molecular diagnostics for all

Jabed Iqbal; Priyangie N Amarabandu

doi:10.1136/bmjonc-2026-001113

January 1, 2026BMJ OncologyOpen Access

Beyond a two-tier model: equitable molecular diagnostics for all

View Full Paper

Ask AI

Bookmark

Share

Key Points

The aim is to explore how molecular, genomic, and epigenetic biomarkers can enhance oncological diagnostics and patient care.
Examined the integration of molecular and genetic tools in cancer diagnosis and treatment.
Analyzed the impact of these tools on tumor classification and management.
Focused on equitable access to molecular diagnostics.
Enhanced tumor classification through the use of genomic and epigenetic markers.
Improved management of cancer patients by integrating advanced molecular diagnostics.
Emphasized the need for equitable access to these diagnostic tools for all patients.

Ask about this paper

Answers are grounded in this paper and cite their sources.

Implication

Investigates molecular diagnostics in oncology, suggesting broader access to precision medicine.

Abstract

The integration of molecular, genomic and epigenetic biomarkers into oncological diagnostics represents a paradigm shift in precision medicine, fundamentally transforming tumour classification and management.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Iqbal et al. (2026) studied this question.

synapsesocial.com/papers/6a17dc453fad632b0f9d8e92 https://doi.org/10.1136/bmjonc-2026-001113

View Full Paper

Ask AI

Bookmark

Share

Beyond a two-tier model: equitable molecular diagnostics for all

Key Points

Ask about this paper

Implication

Abstract

Discussion

Cite This Study

Beyond a two-tier model: equitable molecular diagnostics for all

Key Points

Ask about this paper

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading